EMR vs TT vs ITW
161 measures in 16 categories, one definition each, computed from filings and market data.
EMR63.4
Emerson Electric Co.
Industrials · Industrial - Machinery
$161.47 −0.43%$90.1B mkt cap
Score DNA
TT66.5
Trane Technologies plc
Industrials · Industrial - Machinery
$458.89 +0.33%$101.0B mkt cap
Score DNA
ITW59.5
Illinois Tool Works Inc.
Industrials · Industrial - Machinery
$272.28 +0.40%$77.5B mkt cap
Score DNA
Price, rebased to 100 three years ago
EMR TT ITW · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 1 |
| Insider $ bought, 180d | — | — | $0.20M |
| Congress purchases, 180d | 1 | 2 | 3 |
| Last Congress purchase | 2026-09-25 | 2026-08-10 | 2026-09-04 |
| 13F net change in holders | +89 | — | +30 |
| ETFs adding shares, 30d | 1,096 | 1,355 | 1,134 |
| ETFs trimming, 30d | 927 | 1,135 | 1,006 |
| Net ETF funds, 30d | +169 | +220 | +128 |
Valuation
16 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| P/E (TTM) | 35.0x
72nd
|
34.2x
70th
|
24.3x
33rd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 1.95
55th
|
8.21
86th
|
| Price / sales | 4.8x
87th
|
4.5x
82nd
|
4.7x
85th
|
| Price / book | 4.4x
67th
|
11.7x
92nd
|
26.8x
98th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 26.0x
64th
|
28.3x
75th
|
26.5x
66th
|
| Price / operating cash flow | 23.0x
72nd
|
25.9x
81st
|
23.3x
76th
|
| Enterprise value | $101.7B
95th
|
$104.3B
97th
|
$86.4B
93rd
|
| EV / sales | 5.5x
90th
|
4.7x
82nd
|
5.2x
87th
|
| EV / EBITDA | 19.1x
68th
|
24.0x
88th
|
18.2x
62nd
|
| EV / EBIT | 26.5x
78th
|
26.4x
74th
|
19.5x
33rd
|
| EV / free cash flow | 29.4x
61st
|
29.2x
59th
|
29.6x
64th
|
| Earnings yield | 2.9%
36th
|
2.9%
38th
|
4.1%
70th
|
| FCF yield | 3.8%
41st
|
3.5%
31st
|
3.8%
39th
|
| Operating cash flow yield | 4.3%
31st
|
3.9%
23rd
|
4.3%
28th
|
| Graham number (per share) | $61.26
63rd
|
$107.64
83rd
|
$50.25
57th
|
Profitability (TTM)
12 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Gross margin | 53.2%
97th
|
35.4%
46th
|
44.2%
84th
|
| EBITDA margin | 28.5%
95th
|
19.5%
56th
|
28.8%
97th
|
| Operating margin | 20.1%
85th
|
17.9%
74th
|
26.5%
97th
|
| EBIT margin | 20.6%
89th
|
17.8%
69th
|
26.9%
98th
|
| Net margin | 13.8%
79th
|
13.3%
74th
|
19.4%
97th
|
| NOPAT margin | 15.8%
82nd
|
14.5%
77th
|
20.5%
97th
|
| FCF margin | 18.6%
90th
|
16.1%
74th
|
17.7%
85th
|
| Operating cash flow margin | 21.0%
90th
|
17.6%
72nd
|
20.2%
87th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
4.1%
92nd
|
| SG&A / revenue | 28.1%
93rd
|
17.4%
46th
|
17.2%
44th
|
| Stock comp / revenue | 1.3%
85th
|
0.4%
23rd
|
0.4%
28th
|
| Effective tax rate | 21.4%
52nd
|
19.0%
27th
|
22.5%
60th
|
Returns on capital
11 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| ROE (on average equity) | 12.8%
51st
|
35.8%
93rd
|
104.7%
100th
|
| ROA | 6.1%
49th
|
13.1%
87th
|
19.6%
100th
|
| ROIC | 9.2%
44th
|
27.0%
92nd
|
28.8%
95th
|
| ROCE | 12.2%
56th
|
25.4%
92nd
|
41.9%
98th
|
| Return on tangible assets | 9.0%
51st
|
17.6%
87th
|
27.2%
100th
|
| Cash ROIC (OCF / invested capital) | 12.2%
47th
|
32.6%
95th
|
28.3%
88th
|
| Gross profitability (GP / assets) | 23.5%
46th
|
32.9%
79th
|
44.1%
97th
|
| ROIC, 3-yr average | 6.9%
30th
|
21.9%
91st
|
25.4%
95th
|
| ROIC, 5-yr average | 18.8%
81st
|
21.9%
94th
|
29.5%
100th
|
| ROE, 5-yr average | 25.9%
93rd
|
32.0%
96th
|
99.5%
100th
|
| Incremental ROIC | -154.4%
12th
|
112.5%
83rd
|
175.6%
90th
|
Growth
17 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Revenue growth (TTM YoY) | 4.8%
40th
|
7.0%
48th
|
4.3%
35th
|
| Revenue growth (QoQ) | 6.8%
38th
|
27.9%
93rd
|
7.1%
39th
|
| Revenue CAGR, 3 yr | 4.3%
59th
|
9.7%
76th
|
0.8%
22nd
|
| Revenue CAGR, 5 yr | 0.9%
4th
|
10.4%
75th
|
3.3%
19th
|
| Gross profit CAGR, 3 yr | 8.6%
63rd
|
13.5%
81st
|
3.4%
31st
|
| Operating income CAGR, 3 yr | 7.3%
53rd
|
14.4%
73rd
|
3.4%
31st
|
| Net income growth (TTM YoY) | -2.8%
49th
|
3.3%
55th
|
-5.1%
43rd
|
| Net income CAGR, 3 yr | -42.0%
2nd
|
16.2%
76th
|
1.0%
39th
|
| EPS growth (TTM YoY) | -2.2%
49th
|
4.5%
59th
|
-3.1%
47th
|
| EPS CAGR, 3 yr | -41.6%
2nd
|
17.5%
76th
|
3.0%
47th
|
| EPS CAGR, 5 yr | 3.3%
26th
|
19.1%
87th
|
5.7%
41st
|
| FCF growth (TTM YoY) | 26.2%
67th
|
27.0%
69th
|
7.2%
40th
|
| FCF CAGR, 3 yr | 18.0%
62nd
|
32.9%
79th
|
4.1%
21st
|
| Operating cash flow CAGR, 3 yr | 16.1%
58th
|
29.3%
81st
|
3.1%
21st
|
| Book value CAGR, 3 yr | 0.6%
11th
|
12.5%
64th
|
-0.3%
9th
|
| Dividend CAGR, 3 yr | 1.8%
44th
|
4.6%
84th
|
3.8%
70th
|
| Sustainable growth rate | 6.7%
33rd
|
25.1%
91st
|
44.6%
96th
|
Margin history & stability
7 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Gross margin, 3-yr average | 52.0%
97th
|
35.4%
48th
|
43.5%
82nd
|
| Operating margin, 3-yr average | 18.2%
82nd
|
17.8%
77th
|
26.3%
98th
|
| Net margin, 3-yr average | 13.0%
75th
|
13.1%
78th
|
20.0%
97th
|
| FCF margin, 3-yr average | 13.7%
73rd
|
14.3%
80th
|
17.6%
93rd
|
| Revenue stability (0-1) | 0.16
7th
|
1.00
100th
|
0.73
40th
|
| Earnings stability (0-1) | 0.02
12th
|
0.97
100th
|
0.77
78th
|
| Margin stability (0-1) | 0.90
25th
|
0.94
57th
|
0.97
78th
|
Liquidity (latest quarter)
7 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Cash & short-term investments | $2.2B
95th
|
$1.3B
89th
|
$839.0M
84th
|
| Net cash (− = net debt) | −$11.6B
0th
|
−$3.3B
15th
|
−$8.9B
3rd
|
| Working capital | −$1.1B
3rd
|
$615.9M
52nd
|
$647.0M
61st
|
| Current ratio | 0.90
3rd
|
1.07
7th
|
1.11
10th
|
| Quick ratio | 0.66
3rd
|
0.76
16th
|
0.81
20th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.20
34th
|
0.16
26th
|
0.14
20th
|
| Defensive interval (days) | 310 days
16th
|
523 days
61st
|
552 days
64th
|
Leverage & solvency (latest quarter)
13 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Total debt | $13.8B
98th
|
$4.6B
85th
|
$9.7B
95th
|
| Debt / equity | 0.68
65th
|
0.53
47th
|
3.35
97th
|
| Net debt / equity | 0.57
70th
|
0.38
48th
|
3.06
98th
|
| Debt / assets | 32.7%
70th
|
19.3%
26th
|
58.8%
97th
|
| Debt / capital | 40.4%
65th
|
34.8%
47th
|
77.0%
97th
|
| Debt / EBITDA | 2.60
64th
|
1.06
16th
|
2.05
54th
|
| Net debt / EBITDA | 2.19
71st
|
0.76
29th
|
1.87
62nd
|
| Interest coverage (EBIT / interest) | 6.9x
46th
|
18.0x
84th
|
14.6x
77th
|
| Cash interest coverage | 7.1x
41st
|
17.7x
86th
|
11.0x
68th
|
| Debt payback (years of OCF) | 3.5 yrs
62nd
|
1.2 yrs
19th
|
2.9 yrs
57th
|
| Liabilities / assets | 51.7%
52nd
|
63.9%
79th
|
82.4%
93rd
|
| IS credit model rating | A- | AA+ | AA- |
| Implied credit spread (bps) | 175
66th
|
65
5th
|
100
21st
|
Efficiency
11 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Asset turnover | 0.44
8th
|
0.99
70th
|
1.01
79th
|
| Fixed asset turnover | 6.51
59th
|
9.28
87th
|
7.37
70th
|
| Inventory turnover | 3.6
48th
|
5.8
92nd
|
5.3
87th
|
| Receivables turnover | 6.2
56th
|
5.3
30th
|
4.8
16th
|
| Days sales outstanding | 58 days
44th
|
68 days
70th
|
76 days
84th
|
| Days inventory outstanding | 100 days
52nd
|
63 days
8th
|
69 days
13th
|
| Days payables outstanding | 60 days
64th
|
70 days
82nd
|
25 days
2nd
|
| Cash conversion cycle (days) | 98 days
34th
|
62 days
8th
|
120 days
61st
|
| Capex / revenue | 2.4%
53rd
|
1.5%
7th
|
2.5%
55th
|
| Capex / depreciation | 0.30
7th
|
0.84
67th
|
1.29
85th
|
| Operating expense ratio | 33.9%
95th
|
16.3%
28th
|
17.5%
33rd
|
Cash flow & earnings quality
7 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Operating cash flow / net income | 1.52
60th
|
1.32
38th
|
1.04
13th
|
| FCF / net income | 1.34
67th
|
1.21
49th
|
0.91
18th
|
| FCF / operating cash flow | 88.4%
74th
|
91.5%
89th
|
87.7%
67th
|
| Capex / operating cash flow | 11.6%
26th
|
8.5%
11th
|
12.3%
33rd
|
| Accruals ratio | -3.2%
54th
|
-4.2%
36th
|
-0.8%
87th
|
| Sloan accruals ratio | -2.2%
36th
|
-2.1%
38th
|
-12.1%
2nd
|
| Earnings quality score (0-1) | 1.00
25th
|
1.00
25th
|
1.00
25th
|
Scores & forensic checks
15 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| IS score | 63
70th
|
66
79th
|
60
56th
|
| IS profitability | 57
67th
|
67
84th
|
84
98th
|
| IS growth | 41
37th
|
50
57th
|
50
58th
|
| IS value | 46
41st
|
34
11th
|
46
38th
|
| IS momentum | 71
48th
|
76
60th
|
63
27th
|
| IS risk (safety) | 100
48th
|
100
48th
|
100
48th
|
| IS quality | 80
82nd
|
79
80th
|
59
18th
|
| IS balance sheet | 54
31st
|
65
54th
|
43
15th
|
| IS earnings quality | 77
79th
|
72
51st
|
71
38th
|
| IS cash flow | 73
84th
|
76
85th
|
60
52nd
|
| Piotroski F-score (0-9) | 8
74th
|
6
36th
|
6
36th
|
| Altman Z-score | 4.3
49th
|
6.4
84th
|
8.0
93rd
|
| Beneish M-score | −2.61
30th
|
−2.56
47th
|
−2.46
68th
|
| Ohlson O-score | −8.50
31st
|
−7.93
52nd
|
−6.81
80th
|
| IS credit score | 67
33rd
|
90
92nd
|
81
57th
|
Size (TTM)
8 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| Market cap | $90.1B
95th
|
$101.0B
97th
|
$77.5B
93rd
|
| Revenue | $18.6B
90th
|
$22.2B
95th
|
$16.5B
89th
|
| EBITDA | $5.3B
97th
|
$4.3B
92nd
|
$4.7B
93rd
|
| Net income | $2.6B
92nd
|
$2.9B
95th
|
$3.2B
97th
|
| Free cash flow | $3.5B
95th
|
$3.6B
97th
|
$2.9B
90th
|
| Total assets | $42.2B
97th
|
$23.9B
90th
|
$16.5B
85th
|
| Shareholders' equity | $20.4B
100th
|
$8.6B
87th
|
$2.9B
69th
|
| Employees | 71,000
97th
|
44,000
90th
|
43,000
89th
|
Price performance
9 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| 1 day | −0.4% | +0.3% | +0.4% |
| 1 week | −0.2% | −3.8% | +3.1% |
| 1 month | +9.5% | +8.4% | +2.4% |
| 3 months | +18.2% | −1.8% | +0.2% |
| 6 months | +10.3% | −3.2% | +0.0% |
| Year to date | +19.3% | +16.1% | +9.1% |
| 1 year | +24.5% | +9.7% | +9.9% |
| 3 years, cumulative | +73.3% | +123.8% | +20.6% |
| 5 years, cumulative | +82.3% | +184.1% | +38.1% |
Technicals
4 measures| Measure | EMR | TT | ITW |
|---|---|---|---|
| RSI 14 | 57.6 | 49.8 | 56.1 |
| From 52-week high | −2.6% | −9.1% | −10.2% |
| From 52-week low | +31.6% | +32.8% | +14.0% |
| Beta | 1.21 | 1.16 | 0.97 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17